MRI-guided breast biopsy based on diffusion-weighted imaging: a feasibility study.
Biopsy
Breast
Diffusion magnetic resonance imaging
Feasibility studies
Magnetic resonance imaging
Journal
European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
received:
11
05
2020
accepted:
08
10
2020
revised:
13
08
2020
pubmed:
1
11
2020
medline:
16
4
2021
entrez:
31
10
2020
Statut:
ppublish
Résumé
This study evaluated the feasibility of DWI for lesion targeting in MRI-guided breast biopsies. Furthermore, it assessed device positioning on DWI during biopsy procedures. A total of 87 biopsy procedures (5/87 bilateral) consecutively performed between March 2019 and June 2020 were retrospectively reviewed: in these procedures, a preliminary DWI sequence (b = 1300 s/mm Mass lesions ranged from 5 to 48 mm, with a mean size of 10.7 mm and a median size of 8 mm. Non-mass lesions ranged from 7 to 90 mm, with a mean size of 33.9 mm and a median size of 31 mm. Positioning of the coaxial system was confirmed on both T1-weighted and DWI sequences. At DWI, the biopsy needle was detectable in 62/64 (96.9%) cases; it was not visible in 2/64 (3.1%) cases. The site marker was always identified using T1-weighted imaging; a final DWI sequence was acquired in 44/64 cases (68.8%). In 42/44 cases (95.5%), the marker was recognizable at DWI. DWI can be used as a cost-effective, highly reliable technique for targeting both mass and non-mass lesions, with a minimum size of 5 mm, detectable at pre-procedural DWI. DWI is also a feasible technique to localize the biopsy device and to confirm the deployment of the site marker. • MRI-guided breast biopsy is performed in referral centers by an expert dedicated staff, based on prior MR imaging; contrast agent administration is usually needed for lesion targeting. • DWI represents a feasible, highly reliable technique for lesion targeting, avoiding contrast agent administration. • DWI allows a precise localization of both biopsy needle device and site marker.
Identifiants
pubmed: 33128183
doi: 10.1007/s00330-020-07396-2
pii: 10.1007/s00330-020-07396-2
pmc: PMC8043934
doi:
Substances chimiques
Contrast Media
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2645-2656Références
Sardanelli F, Boetes C, Borisch B et al (2010) Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer 46(8):1296–1316. https://doi.org/10.1016/j.ejca.2010.02.015
doi: 10.1016/j.ejca.2010.02.015
Peters NHGM, Borel Rinkes IHM, Zuithoff NPA, Mali WPTM, Moons KGM, Peeters PHM (2008) Meta-analysis of MR imaging in the diagnosis of breast lesions. Radiology 246(1):116–124. https://doi.org/10.1148/radiol.2461061298
doi: 10.1148/radiol.2461061298
pubmed: 18024435
Mann RM, Cho N, Moy L (2019) Breast MRI: state of the art. Radiology 292(3):520–536. https://doi.org/10.1148/radiol.2019182947
doi: 10.1148/radiol.2019182947
pubmed: 31361209
Pinker K, Moy L, Sutton EJ et al (2018) Diffusion-weighted imaging with apparent diffusion coefficient mapping for breast cancer detection as a stand-alone parameter. Invest Radiol 53(10):587–595. https://doi.org/10.1097/RLI.0000000000000465
doi: 10.1097/RLI.0000000000000465
pubmed: 29620604
pmcid: 6123254
Schell AM, Rosenkranz K, Lewis PJ (2009) Role of breast MRI in the preoperative evaluation of patients with newly diagnosed breast cancer. AJR Am J Roentgenol 192:1438–1444. https://doi.org/10.2214/AJR.08.1551
doi: 10.2214/AJR.08.1551
pubmed: 19380574
Pinker K, Bogner W, Baltzer P et al (2014) Clinical application of bilateral high temporal and spatial resolution dynamic contrast enhanced magnetic resonance imaging of the breast at 7T. Eur Radiol 24:913–920. https://doi.org/10.1007/s00330-013-3075-8
doi: 10.1007/s00330-013-3075-8
pubmed: 24306425
Martincich L, Faivre-Pierret M, Zechmann CM et al (2011) Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for breast MR imaging (DETECT trial). Radiology 258:396–408. https://doi.org/10.1148/radiol.10100968
doi: 10.1148/radiol.10100968
pubmed: 21163915
Zhang L, Tang M, Min Z, Lu J, Lei X, Zhang X (2016) Accuracy of combined dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging for breast cancer detection: a meta-analysis. Acta Radiol 57(6):651–660. https://doi.org/10.1177/0284185115597265
doi: 10.1177/0284185115597265
pubmed: 26275624
Baltzer P, Mann RM, Lima M et al (2020) Diffusion-weighted imaging of the breast—a consensus and mission statement from the EUSOBI International Breast Diffusion-Weighted Imaging working group. Eur Radiol 30:1436–1450. https://doi.org/10.1007/s00330-019-06510-3
doi: 10.1007/s00330-019-06510-3
pubmed: 31786616
Dietzel M, Ellmann S, Schulz-Wendtland R et al (2020) Breast MRI in the era of diffusion weighted imaging: do we still need signal-intensity time curves? Eur Radiol 30:47–56. https://doi.org/10.1007/s00330-019-06346-x
doi: 10.1007/s00330-019-06346-x
pubmed: 31359125
Dorrius MD, Dijkstra H, Oudkerk M, Sijens PE (2014) Effect of b value and pre-admission of contrast on diagnostic accuracy of 1.5-T breast DWI: a systematic review and meta-analysis. Eur Radiol 24:2835–2847. https://doi.org/10.1007/s00330-014-3338-z
doi: 10.1007/s00330-014-3338-z
pubmed: 25103535
Santiago L, Candelaria RP, Huang ML (2018) MR imaging–guided breast interventions: indications, key principles, and imaging-pathology correlation. Magn Reson Imaging Clin N Am 26(2):235–246. https://doi.org/10.1016/j.mric.2017.12.002
doi: 10.1016/j.mric.2017.12.002
pubmed: 29622128
McGrath AL, Price ER, Eby PR, Rahbar H (2017) MRI-guided breast interventions. J Magn Reson Imaging 46(3):631–645. https://doi.org/10.1002/jmri.25738
doi: 10.1002/jmri.25738
pubmed: 28470744
Abe H, Schmidt RA, Shah RN et al (2010) MR-directed (“second-look”) ultrasound examination for breast lesions detected initially on MRI: MR and sonographic findings. AJR Am J Roentgenol 194:370–377. https://doi.org/10.2214/AJR.09.2707
doi: 10.2214/AJR.09.2707
pubmed: 20093598
Mann RM, Kuhl CK, Kinkel K, Boetes C (2008) Breast MRI: guidelines from the European Society of Breast Imaging. Eur Radiol 18(7):1307–1318. https://doi.org/10.1007/s00330-008-0863-7
doi: 10.1007/s00330-008-0863-7
pubmed: 18389253
pmcid: 2441490
Heywang-Kobrunner SH, Sinnatamby R, Lebeau A et al (2009) Interdisciplinary consensus on the uses and technique of MRguided vacuum-assisted breast biopsy (VAB): results of a European consensus meeting. Eur J Radiol 72:289–294. https://doi.org/10.1016/j.ejrad.2008.07.010
doi: 10.1016/j.ejrad.2008.07.010
pubmed: 18723305
Chopier J, Dratwa C, Antoine M, Gonin J, Thomassin Naggara I (2014) Radiopathological correlations: masses, non-masslike enhancements and MRI-guided biopsy. Diagn Interv Imaging 95(2):213–225. https://doi.org/10.1016/j.diii.2013.12.007
doi: 10.1016/j.diii.2013.12.007
pubmed: 24456894
Imschweiler T, Haueisen H, Kampmann G et al (2014) MRI guided vacuum-assisted breast biopsy: comparison with stereotactically guided and ultrasound-guided techniques. Eur Radiol 24:128–135. https://doi.org/10.1007/s00330-013-2989-5
doi: 10.1007/s00330-013-2989-5
pubmed: 23979106
Rauch GM, Dogan BE, Smith TB, Liu P, Yang WT (2012) Outcome analysis of 9-gauge MRI-guided vacuum-assisted core needle breast biopsies. AJR Am J Roentgenol 198:292–299. https://doi.org/10.2214/AJR.11.7594
doi: 10.2214/AJR.11.7594
pubmed: 22268171
pmcid: 4111151
Malhaire C, El Khoury C, Thibault F et al (2010) Vacuum-assisted biopsies under MR guidance: results of 72 procedures. Eur Radiol 20:1554–1562. https://doi.org/10.1007/s00330-009-1707-9
doi: 10.1007/s00330-009-1707-9
pubmed: 20119729
Ferré R, Ianculescu V, Ciolovan L et al (2016) Diagnostic performance of MR-guided vacuum-assisted breast biopsy: 8 years of experience. Breast J 22(1):83–89. https://doi.org/10.1111/tbj.12519
doi: 10.1111/tbj.12519
pubmed: 26511082
Spick C, Schernthaner M, Pinker K et al (2016) MR-guided vacuum-assisted breast biopsy of MRI-only lesions: a single center experience. Eur Radiol 26(11):3908–3916. https://doi.org/10.1007/s00330-016-4267-9
doi: 10.1007/s00330-016-4267-9
pubmed: 26984430
pmcid: 5052307
Papalouka V, Kilburn-Toppin F, Gaskarth M, Gilbert F (2018) MRI-guided breast biopsy: a review of technique, indications, and radiological–pathological correlations. Clin Radiol 73(10):908.e17–908.e25. https://doi.org/10.1016/j.crad.2018.05.029
doi: 10.1016/j.crad.2018.05.029
Chevrier MC, David J, El Khoury M, Lalonde L, Labelle M, Trop I (2016) Breast biopsies under magnetic resonance imaging guidance: challenges of an essential but imperfect technique. Curr Probl Diagn Radiol 45(3):193–204. https://doi.org/10.1067/j.cpradiol.2015.07.002
doi: 10.1067/j.cpradiol.2015.07.002
pubmed: 26272705
McDonald RJ, McDonald JS, Kallmes DF et al (2017) Gadolinium deposition in human brain tissues after contrast-enhanced MR imaging in adult patients without intracranial abnormalities. Radiology 285:2. https://doi.org/10.1148/radiol.2017161595
doi: 10.1148/radiol.2017161595
United States Food and Drug Administration (2017) FDA Safety Announcement - FDA identifies no harmful effects to date with brain retention of gadolinium-based contrast agents for MRIs; review to continue. Available via https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-identifies-no-harmful-effects-date-brain-retention-gadolinium Accessed 01 May 2020
European Medicines Agency (2017) EMA gadolinium-containing contrast agents recommendations. Available via https://www.emaeuropaeu/en/medicines/human/referrals/gadolinium-containing-contrast-agents Accessed 11 Jun 2020
Yeh ED, Georgian-Smith D, Raza S, Bussolari L, Pawlisz-Hoff J, Birdwell RL (2014) Positioning in breast MR imaging to optimize image quality. Radiographics 34(1):E1–E17. https://doi.org/10.1148/rg.341125193
doi: 10.1148/rg.341125193
pubmed: 24428300
Berger N, Varga Z, Frauenfelder T, Boss A (2017) MRI-guided breast vacuum biopsy: localization of the lesion without contrast-agent application using diffusion-weighted imaging. Magn Reson Imaging 38:1–5. https://doi.org/10.1016/j.mri.2016.12.006
doi: 10.1016/j.mri.2016.12.006
pubmed: 27979690
Partridge SC, McDonald ES (2013) Diffusion weighted magnetic resonance imaging of the breast: protocol optimization, interpretation, and clinical applications. Magn Reson Imaging Clin N Am 21(3):601–624. https://doi.org/10.1016/j.mric.2013.04.007
doi: 10.1016/j.mric.2013.04.007
pubmed: 23928248
pmcid: 3740446
Partridge SC, Nissan N, Rahbar H, Kitsch AE, Sigmund EE (2017) Diffusion-weighted breast MRI: clinical applications and emerging techniques. J Magn Reson Imaging 45(2):337–355. https://doi.org/10.1002/jmri.25479
doi: 10.1002/jmri.25479
pubmed: 27690173
Kuhl CK, Gieseke J, von Falkenhausen M et al (2005) Sensitivity encoding for diffusion-weighted MR imaging at 3.0 T: intraindividual comparative study. Radiology 234:517–526. https://doi.org/10.1148/radiol.2342031626
doi: 10.1148/radiol.2342031626
pubmed: 15671005
Teruel JR, Fjosne HE, Ostlie A et al (2015) Inhomogeneous static magnetic field-induced distortion correction applied to diffusion weighted MRI of the breast at 3T. Magn Reson Med 74:1138–1144. https://doi.org/10.1002/mrm.25489
doi: 10.1002/mrm.25489
pubmed: 25323982
Avendano D, Marino MA, Leithner D et al (2019) Limited role of DWI with apparent diffusion coefficient mapping in breast lesions presenting as non-mass enhancement on dynamic contrast-enhanced MRI. Breast Cancer Res 21:136. https://doi.org/10.1186/s13058-019-1208-y
doi: 10.1186/s13058-019-1208-y
pubmed: 31801635
pmcid: 6894318